DefiniGEN
Parkwalk closes DefiniGen investment for the University of Cambridge Enterprise Fund I DefiniGEN provides human cells to the drug discovery sector for use in lead optimization and toxicity programmes. The Company’s proprietary production platform OptiDIFF robustly generates human… Read More
University of Cambridge Enterprise Fund Launch
University of Cambridge launches new investment scheme for start-ups Cambridge is launching a new investment scheme that will help support new companies connected to the University. The new fund, a Seed Enterprise Investment Scheme (SEIS) and Enterprise Investment… Read More
